The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Associate Professor Nina Reistad MSc, PhD

Nina Reistad

Senior lecturer

Associate Professor Nina Reistad MSc, PhD

Two-stage diffuse fluorescence tomography for monitoring of drug distribution in photodynamic therapy of tumors

Author

  • Stefan Šušnjar
  • Muhammad Daniyal Ghauri
  • Björn Thomasson
  • Sanathana Konugolu Venkata Sekar
  • Stefan Andersson-Engels
  • Johannes Swartling
  • Nina Reistad

Summary, in English

Significance
The spatial distribution of the photosensitizing drug concentration is an important parameter for predicting the photodynamic therapy (PDT) outcome. Current diffuse fluorescence tomography methods lack accuracy in quantifying drug concentration. The development of accurate methods for monitoring the temporal evolution of the drug distribution in tissue can advance the real-time light dosimetry in PDT of tumors, leading to better treatment outcomes.

Aim
We develop diffuse optical tomography methods based on interstitial fluorescence measurements to accurately reconstruct the spatial distribution of fluorescent photosensitizing drugs in real-time.

Approach
A two-stage reconstruction algorithm is proposed. The capabilities and limitations of this method are studied in various simulated scenarios. For the first time, experimental validation is conducted using the clinical system for interstitial PDT of prostate cancer on prostate tissue-mimicking phantoms with the photosensitizer verteporfin.

Results
The average relative error of the reconstructed fluorophore absorption was less than 10%, whereas the fluorescent inclusion reconstructed volume relative error was less than 35%.

Conclusions
The proposed method can be used to monitor the temporal evolution of the photosensitizing drug concentration in tumor tissue during photodynamic therapy. This is an important step forward in the development of the next generation of real-time light dosimetry algorithms for photodynamic therapy.

Department/s

  • LU Profile Area: Light and Materials
  • LTH Profile Area: Engineering Health
  • Atomic Physics
  • Centre for Environmental and Climate Science (CEC)
  • LTH Profile Area: Photon Science and Technology
  • LUCC: Lund University Cancer Centre

Publishing year

2025

Language

English

Publication/Series

Journal of Biomedical Optics

Volume

30

Issue

1

Document type

Article

Publisher

SPIE

Topic

  • Atom and Molecular Physics and Optics

Keywords

  • diffuse optical tomography
  • fluorescence
  • photodynamic therapy
  • photo sensitizing drug
  • inverse problem
  • tissue phantoms
  • SDG 3 - Good Health and Well-being

Status

Published

ISBN/ISSN/Other

  • ISSN: 1083-3668